Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 531 institutions that hold shares in the stock, with a total of 68.7 Million shares, which have been reported (via 13F filing form) to have a value of $3.69 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
719,309
shares
|
$38.6 Million
0.05% of portfolio
|
Q1 2024
Reduced 17.9%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
511,380
shares
|
$27.5 Million
0.0% of portfolio
|
Q2 2025
Reduced 60.66%
|
|
|
Versant Venture Management, LLC
San Francisco, CA |
Aug 11, 2025 Q2 2025 |
498,558
shares
|
$26.8 Million
43.04% of portfolio
|
Q3 2021
Reduced 1.97%
|
|
|
Bank Of Montreal
Toronto, A6 |
Aug 05, 2025 Q2 2025 |
493,743
shares
|
$26.5 Million
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Vestmark Advisory Solutions, Inc.
|
Aug 06, 2025 Q2 2025 |
484,975
shares
|
$26 Million
0.38% of portfolio
|
Q2 2025
Added 115.25%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 13, 2025 Q2 2025 |
406,487
shares
|
$21.8 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
380,623
shares
|
$20.4 Million
0.0% of portfolio
|
Q2 2025
Added 324.68%
|
|
|
Contrarius Group Holdings LTD
Hamilton, D0 |
Aug 12, 2025 Q2 2025 |
374,954
shares
|
$20.1 Million
1.03% of portfolio
|
Q2 2025
Added 12.95%
|
|
|
Jump Financial, LLC
Chicago, IL |
Aug 13, 2025 Q2 2025 |
356,306
shares
|
$19.1 Million
0.22% of portfolio
|
Q2 2025
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
337,138
shares
|
$18.1 Million
0.0% of portfolio
|
Q2 2025
Added 136.26%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
295,987
shares
|
$15.9 Million
0.0% of portfolio
|
Q1 2025
Added 2.35%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Aug 14, 2025 Q2 2025 |
262,089
shares
|
$14.1 Million
0.0% of portfolio
|
Q2 2025
Added 20.19%
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
235,920
shares
|
$12.7 Million
0.01% of portfolio
|
Q2 2025
Reduced 4.13%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
235,740
shares
|
$12.7 Million
0.0% of portfolio
|
Q2 2025
Reduced 11.22%
|
|
|
Td Asset Management Inc
|
Jul 28, 2025 Q2 2025 |
228,416
shares
|
$12.3 Million
0.01% of portfolio
|
Q2 2025
Reduced 5.74%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
220,600
shares
|
$11.8 Million
0.0% of portfolio
|
Q2 2025
Added 49.73%
|
|
|
Iq Eq Fund Management (Ireland) LTD
|
Aug 01, 2025 Q2 2025 |
195,602
shares
|
$10.5 Million
0.87% of portfolio
|
Q2 2025
Added 200.03%
|
|
|
Lpl Financial LLC
Fort Mill, SC |
Aug 12, 2025 Q2 2025 |
194,579
shares
|
$10.4 Million
0.0% of portfolio
|
Q2 2025
Added 4.92%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
184,853
shares
|
$9.92 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Swiss National Bank
Zurich, V8 |
May 12, 2025 Q1 2025 |
157,100
shares
|
$8.43 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.26%
|
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
149,267
shares
|
$8.01 Million
0.04% of portfolio
|
Q2 2025
Added 9.37%
|
|
|
Legal & General Group PLC
London, X0 |
Aug 12, 2025 Q2 2025 |
129,567
shares
|
$6.96 Million
0.0% of portfolio
|
Q2 2025
Added 59.65%
|
|
|
Nordea Investment Management Ab
Stockholm, V7 |
Jul 29, 2025 Q2 2025 |
127,500
shares
|
$6.85 Million
0.01% of portfolio
|
Q2 2025
Added 0.71%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
126,892
shares
|
$6.81 Million
0.0% of portfolio
|
Q2 2025
Reduced 38.3%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
123,893
shares
|
$6.65 Million
0.01% of portfolio
|
Q2 2025
New holding
|